Assistant ProfessorUniversity of TorontoToronto, Ontario, Canada
OC 05.2 - Impact of heparin on disease state transition in hospitalized, non-critically ill patients with COVID-19; secondary analysis of an international multi-platform RCT
Saturday, June 24, 202313:15 – 13:30 ET
OC 29.4 - Impact of symptom duration on clinical outcomes in hospitalized, non-critically ill patients with COVID-19; secondary analysis of an international multi-platform RCT
Sunday, June 25, 202315:30 – 15:45 ET
PB0052 - Heparin type & clinical outcomes in hospitalized, non-critically ill patients with COVID-19: secondary analysis of an international multi-platform RCT
Sunday, June 25, 202318:30 – 19:30 ET
